skip to main content

Chemistry, part 2

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester

اصطلاح مرجح

butanoic acid [(4as,5r,6r,7ar)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4h-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C18H24N5O8P

اینچی

  • InChI=1S/C18H24N5O8P/c1-3-5-11(24)22-15-13-16(20-8-19-15)23(9-21-13)17-14(29-12(25)6-4-2)10-7-28-32(26,27)31-18(10)30-17/h8-10,14,17-18H,3-7H2,1-2H3,(H,26,27)(H,19,20,22,24)/t10-,14+,17+,18+/m0/s1

اینچی‌کی

  • ZKSUYDZTGVUZGX-VBJMPTANSA-N

جرم

  • 469.386

جرم تک‌ایزوتوپی

  • 469.13625

اسمایلٓ

  • CCCC(=O)NC1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]4COP(=O)(O[C@H]4O3)O)OC(=O)CCC

زیرمجموعه

  • 2_STAR

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:91546

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD